Overview
Rachel Stauffer said Democrats are likely to work with the administration on drug-pricing issues, such as transparency and enhancing negotiating power in Medicare Part D, however, the 340B drug discount program may not be a priority. “There is a lack of consensus, even among the parties, about 340B policy,” she said.